Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA)
Jiménez, Alberto, Ais, Arantza, Beaudet, Amélie, Gil, AliciaVolume:
13
Language:
english
Journal:
Orphanet Journal of Rare Diseases
DOI:
10.1186/s13023-018-0966-4
Date:
December, 2018
File:
PDF, 1.05 MB
english, 2018